Contact us

Thank you for your interest in Garg Law PLLC.

Our commitment to understanding your regulatory questions and business goals, and helping you achieve results starts here.

If you are looking for representation on a new matter, please fill out the form below to request a free consultation. The form enables us to conduct a preliminary check for potential conflicts of interest and to determine if we can proceed with the free consultation.

FDA Recall Attorney Serving Miami

Miami — the gateway city — PortMiami, Miami International Airport and the headquarters of hemispheric trade — keeps an FDA recall attorney busier than almost anywhere in America. Miami is the principal port of entry for the southeastern United States — PortMiami and Miami International Airport together move a huge share of the country’s waterborne and air cargo, and the businesses that import, distribute and market FDA-regulated products across the Americas run their operations from here. More FDA-regulated freight crosses this city than almost any other American market. Whether the issue is a detained container at PortMiami, a labeling question before a product launch, or a registration deadline, Miami companies need FDA counsel that works at the port’s pace.

Quick answer

A recall done well is a controlled correction; done badly it is a public unraveling. The legal work spans the decision (is this reportable, is it recallable, what class), the execution (strategy, notifications, effectiveness checks) and the aftermath — FDA follow-up, records, and the enforcement risk that mishandled recalls create.

Why this matters now

Recalls are survivable; botched recalls often are not. Under-scoping invites FDA to force an expansion publicly; ignoring reporting triggers converts a quality issue into a violations case; sloppy execution extends the news cycle and the liability tail. The company’s handling becomes the story — and the regulator’s file.

The rules in plain terms

Most recalls are “voluntary,” but the framework is FDA’s: recalls are classified Class I, II or III by health risk, executed under a written recall strategy with customer notifications, monitored through effectiveness checks, and closed only when FDA agrees disposition is complete. FDA also holds mandatory recall authority — for foods under FSMA, devices under section 518(e), and cosmetics under MoCRA — for firms that refuse to act.

The decision layer is where counsel earns its keep: whether the issue is a recall or a lesser market withdrawal, whether reporting obligations trigger — the Reportable Food Registry for foods, corrections-and-removals reporting for devices — and how the recall scope is defined so it is credible without being ruinous. These calls are made in hours, on incomplete facts, with regulators, insurers and customers all watching.

Execution is operational law: press releases and customer notices with required content, distribution-chain traceback, quarantine and disposition of returned goods, status reports to the FDA district, and the documentation that lets the recall terminate. Import-heavy businesses add a border dimension — recalled lots still arriving in containers, and supplier accountability across borders.

How the process works

  1. Rapid assessment: health hazard evaluation, recall-versus-withdrawal analysis, and reporting-trigger review
  2. Recall strategy drafted to FDA’s framework — depth, scope, notifications, effectiveness-check level
  3. FDA coordination from first notification through status reports to termination
  4. Execution support: notices, traceback, quarantine, disposition and the records behind each
  5. Aftermath management — root-cause corrective actions, supplier claims, and preventing the sequel

Serving Miami from Brickell

The work around Miami — international trade companies, food and beverage importers, cosmetics and consumer brands, medical and pharmaceutical distributors, logistics and freight networks — is FDA-regulated at nearly every turn, and matters here move on the gateway city — PortMiami, Miami International Airport and the headquarters of hemispheric trade. Garg Law's Miami office is at 1221 Brickell Avenue, and the practice was built for exactly this market: founder Shelly Garg spent years counseling importers at the world's largest dedicated international trade law firm before opening her own, and works at the crossroads of FDA and CBP compliance for foreign and domestic companies across the food, beverage, supplement, cosmetics, OTC drug and medical device industries.

Best practices — and common mistakes

  • Calling it a “market withdrawal” to avoid the word recall when the facts say otherwise
  • Missing the 24-hour Reportable Food Registry window while deliberating
  • Scoping the recall to minimize cost instead of matching the actual risk
  • Notifications that skip required content or skip levels of the distribution chain
  • Declaring victory without the effectiveness checks and disposition records FDA expects

Frequently asked questions

Does FDA have to approve a recall before we start?

No — and waiting for permission is a mistake. Firms initiate voluntary recalls immediately and coordinate with FDA in parallel: classification, strategy review and status reporting. FDA involvement shapes the recall; it does not gate the first protective steps.

What is the difference between a recall and a market withdrawal?

A recall corrects a violation of FDA law; a market withdrawal addresses a minor issue involving no violation — a distinction of legal substance, not preference. Misbranding a real recall as a withdrawal is itself the kind of conduct that draws enforcement.

What is the Reportable Food Registry?

The mandatory portal for reporting foods with a reasonable probability of causing serious adverse health consequences — within 24 hours of determination. It applies to registered food facilities, the clock is short, and skipped reports surface later with consequences. The determination process should be designed before the crisis.

Can FDA force a recall if we disagree?

For foods, devices and now cosmetics, yes — mandatory recall authority exists where firms refuse and the risk justifies it. Practically, FDA’s leverage means most “voluntary” recalls are negotiated realities; counsel’s job is shaping scope and narrative inside that reality.

How does a recall end?

With FDA’s agreement to terminate: effectiveness checks done, returned product dispositioned, records complete, root cause corrected. Firms that document as they execute close recalls in months; firms that reconstruct afterward stay in recall status — publicly listed — far longer.

Explore related pages

Request a Consultation

★★★★★

Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.
R.G. Client
I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.
Mike H. Client
Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.
Dr. Sastry Client
I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.
Claire P. Client

News & Insights

Get the latest news on FDA regulatory delivered straight to your inbox.